Literature DB >> 23552464

Prepulse inhibition in HIV-associated neurocognitive disorders.

Arpi Minassian1, Brook L Henry, Steven Paul Woods, Florin Vaida, Igor Grant, Mark A Geyer, William Perry.   

Abstract

Sensorimotor inhibition, or the ability to filter out excessive or irrelevant information, theoretically supports a variety of higher-level cognitive functions. Impaired inhibition may be associated with increased impulsive and risky behavior in everyday life. Individuals infected with HIV frequently show impairment on tests of neurocognitive function, but sensorimotor inhibition in this population has not been studied and may be a contributor to the profile of HIV-associated neurocognitive disorders (HAND). Thirty-seven HIV-infected individuals (15 with HAND) and 48 non-infected comparison subjects were assessed for prepulse inhibition (PPI), an eyeblink startle paradigm measuring sensorimotor gating. Although HIV status alone was not associated with PPI deficits, HIV-positive participants meeting criteria for HAND showed impaired PPI compared to cognitively intact HIV-positive subjects. In HIV-positive subjects, PPI was correlated with working memory but was not associated with antiretroviral therapy or illness factors. In conclusion, sensorimotor disinhibition in HIV accompanies deficits in higher-order cognitive functions, although the causal direction of this relationship requires investigation. Subsequent research on the role of sensorimotor gating on decision-making and risk behaviors in HIV may be indicated.

Entities:  

Mesh:

Year:  2013        PMID: 23552464      PMCID: PMC3729041          DOI: 10.1017/S1355617713000301

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  58 in total

Review 1.  Executive functions and self-regulation.

Authors:  Wilhelm Hofmann; Brandon J Schmeichel; Alan D Baddeley
Journal:  Trends Cogn Sci       Date:  2012-02-13       Impact factor: 20.229

2.  Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons.

Authors:  David J Moore; Miguel Arce; Suzanne Moseley; J Allen McCutchan; Jennifer Marquie-Beck; Donald R Franklin; Florin Vaida; Cristian L Achim; Justin McArthur; Susan Morgello; David M Simpson; Benjamin B Gelman; Ann C Collier; Christina M Marra; David B Clifford; Robert K Heaton; Igor Grant
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

3.  Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder.

Authors:  Susanne E Ahmari; Victoria B Risbrough; Mark A Geyer; H Blair Simpson
Journal:  Neuropsychopharmacology       Date:  2012-01-04       Impact factor: 7.853

4.  Implications of apathy for everyday functioning outcomes in persons living with HIV infection.

Authors:  Rujvi Kamat; Steven Paul Woods; Thomas D Marcotte; Ronald J Ellis; Igor Grant
Journal:  Arch Clin Neuropsychol       Date:  2012-06-15       Impact factor: 2.813

5.  Failure to sustain prepulse inhibition in adolescent marijuana users.

Authors:  Charles W Mathias; Terry D Blumenthal; Michael A Dawes; Anthony Liguori; Dawn M Richard; Bethany Bray; Weiqun Tong; Donald M Dougherty
Journal:  Drug Alcohol Depend       Date:  2010-12-31       Impact factor: 4.492

6.  The relationship between acoustic startle response measures and cognitive functions in Japanese patients with schizophrenia.

Authors:  Taro Kishi; Yasuhisa Fukuo; Tomo Okochi; Kunihiro Kawashima; Masatsugu Moriwaki; Osamu Furukawa; Kiyoshi Fujita; Giovanna M Musso; Christoph U Correll; John M Kane; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2012-03-28       Impact factor: 3.843

7.  Sensorimotor gating changes across the estrous cycle in female rats.

Authors:  M Koch
Journal:  Physiol Behav       Date:  1998-07

8.  Differential cognitive impairment in HCV coinfected men with controlled HIV compared to HCV monoinfection.

Authors:  Bing Sun; Linda Abadjian; Hans Rempel; Alexander Monto; Lynn Pulliam
Journal:  J Acquir Immune Defic Syndr       Date:  2013-02-01       Impact factor: 3.731

9.  Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings.

Authors:  K Blackstone; D J Moore; D R Franklin; D B Clifford; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; R J Ellis; J H Atkinson; I Grant; R K Heaton
Journal:  Clin Neuropsychol       Date:  2012-06-18       Impact factor: 3.535

10.  Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study.

Authors:  John A Joska; Jennifer Westgarth-Taylor; Jacqueline Hoare; Kevin G F Thomas; Robert Paul; Landon Myer; Dan J Stein
Journal:  BMC Infect Dis       Date:  2012-02-15       Impact factor: 3.090

View more
  24 in total

1.  Temporal processsing demands in the HIV-1 transgenic rat: Amodal gating and implications for diagnostics.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2016-12-28       Impact factor: 2.457

2.  Exposure to HIV-1 Tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice.

Authors:  Jason J Paris; Harminder D Singh; Amanda N Carey; Jay P McLaughlin
Journal:  Behav Brain Res       Date:  2015-05-22       Impact factor: 3.332

Review 3.  Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.

Authors:  Virawudh Soontornniyomkij; James P Kesby; Erin E Morgan; Amanda Bischoff-Grethe; Arpi Minassian; Gregory G Brown; Igor Grant
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-02       Impact factor: 4.147

4.  Tryptophan degradation is associated with risk-taking propensity in methamphetamine users with treated HIV infection.

Authors:  Jared Lee; Ji-Young Lee; Christina S Meade; Michael Cohn; Antonio Chahine; Samantha E Dilworth; Jessica F Magidson; Hetta Gouse; Dietmar Fuchs; Adam W Carrico
Journal:  J Neurovirol       Date:  2020-07-29       Impact factor: 2.643

5.  Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2016-08-18       Impact factor: 2.643

6.  Diagnostic and prognostic biomarkers for HAND.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2019-01-03       Impact factor: 2.643

7.  Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.

Authors:  Brook L Henry; Mark A Geyer; Mahalah R Buell; William Perry; Jared W Young; Arpi Minassian
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

8.  A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic Rat.

Authors:  Kristen A McLaurin; Landhing M Moran; Hailong Li; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neuroimmune Pharmacol       Date:  2016-10-03       Impact factor: 4.147

9.  Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.

Authors:  Sylvia Fitting; Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2017-10-27       Impact factor: 2.457

Review 10.  Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.

Authors:  Rowan Saloner; Jerel Adam Fields; Maria Cecilia Garibaldi Marcondes; Jennifer E Iudicello; Sofie von Känel; Mariana Cherner; Scott L Letendre; Marcus Kaul; Igor Grant
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-15       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.